Innovative Questions in Symptom Science and Genomics (R15)

The summary for the Innovative Questions in Symptom Science and Genomics (R15) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

Innovative Questions in Symptom Science and Genomics (R15): This initiative seeks to optimize innovation, insight and cutting edge conceptual and technological breakthroughs by catalyzing research that emanates from the identified innovative questions in symptom and genomic nursing science. These innovative questions are reflective of broad domains from which more specific novel hypotheses or problems to be solved can be derived.

Federal Grant Title:	Innovative Questions in Symptom Science and Genomics (R15)
Federal Agency Name:	National Institutes of Health
Grant Categories:	Education Health
Type of Opportunity:	Discretionary
Funding Opportunity Number:	PA-16-022
Type of Funding:	Grant
CFDA Numbers:	93.361
CFDA Descriptions:	Nursing Research
Current Application Deadline:	Jan 7, 2019
Original Application Deadline:	Jan 7, 2019
Posted Date:	Oct 30, 2015
Creation Date:	Oct 30, 2015
Archive Date:	Feb 7, 2019
Total Program Funding:
Maximum Federal Grant Award:	$300,000
Minimum Federal Grant Award:	none
Expected Number of Awards:
Cost Sharing or Matching:	No

Applicants Eligible for this Grant: Public and State controlled institutions of higher education
Private institutions of higher education
Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility: Other Eligible Applicants include the following:
Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Tribally Controlled Colleges and Universities (TCCUs) ; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.
Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
Link to Full Grant Announcement: http://grants.nih.gov/grants/guide/pa-files/PA-16-022.html
Grant Announcement Contact: NIH OER Webmaster [email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster

National Institutes of Health 301-496-3405
Similar Government Grants: • Clinical-Community Linkages to Address Unmet Social Needs and Adverse Social Determinants ...; • Nursing Research Education Program in Firearm Injury Prevention Research: Short Courses (R...; • Short Courses in Social Determinants of Health for Research Education in Nursing Research ...; • PHS 2023-2 Omnibus Solicitation of the NIH and CDC for Small Business Innovation Research ...; • Clinical-Community Linkages to Address Social Needs and Social Conditions to Advance Healt...; • Ninr Career Transition Award (K22); • Ruth L. Kirschstein National Research Service Award (NRSA) for Individual Predoctoral Fell...; • NINR Mentored Research Scientist Development Award for Underrepresented or Disadvantaged I...
More Grants from the National Institutes of Health: • Promoting Broad Participation in NIDCD's Extramural Workforce through Research Education E...; • HEAL Initiative-Early-Stage Discovery of New Pain Targets Within the Understudied Druggabl...; • Optimizing Behavioral Sleep Interventions for Adolescents and Young Adults (R34 Clinical T...; • Global Infectious Disease Research Training Program (D43 Clinical Trial Optional); • Using Neuromodulation to Characterize the Continuum of Pathophysiology Between Substance U...